A group 1 hemagglutinin stem vaccine elicits broad humoral responses against influenza in phase 1/2a study

N Nina Hertoghs C Chan Tang (Johnson & Johnson Innovative Medicine) V Vitalija van Paassen M Mandy Jongeneelen (Johnson and Johnson Innovative Medicine) J Jeroen Tolboom L Lynn Yieh M Miao Wang K Krisztian Kaszas C Chelsea McLean S Sara van den Berg D David Lowson W Weihong Hu Z Zuleima Aguilar J Jenny Hendriks H Harmjan Kuipers S Sarah Kulke J Jerald Sadoff B Boerries Brandenburg (Johnson and Johnson Innovative Medicine) R Roland Zahn (Johnson & Johnson Innovative Medicine, Leiden, the Netherlands)

Article Details

Volume / Issue Vol. 17, Issue 1
Published April 13, 2026
ISSN 2041-1723
Publisher Nature Portfolio

Journal Info

Nature Communications

Nature Portfolio

ISSN: 2041-1723 Open Access Life Sciences

Authors (19)

N

Nina Hertoghs

C

Chan Tang

Johnson & Johnson Innovative Medicine

V

Vitalija van Paassen

M

Mandy Jongeneelen

Johnson and Johnson Innovative Medicine

J

Jeroen Tolboom

L

Lynn Yieh

M

Miao Wang

K

Krisztian Kaszas

C

Chelsea McLean

S

Sara van den Berg

D

David Lowson

W

Weihong Hu

Z

Zuleima Aguilar

J

Jenny Hendriks

H

Harmjan Kuipers

S

Sarah Kulke

J

Jerald Sadoff

B

Boerries Brandenburg

Johnson and Johnson Innovative Medicine

R

Roland Zahn

Johnson & Johnson Innovative Medicine, Leiden, the Netherlands